Charles Schwab
CANO

Charles Schwab’s Cano Health, Inc. CANO Stock Holding History

Charles Schwab’s Portfolio CANO Stock Details CANO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-7,161
Closed -$182K – 3600
2023
Q3 		$182K Sell
7,161
-9,176
-56% -$754K ﹤0.01% 3302
2023
Q2 		$2.27M Buy
16,337
+5,112
+46% +$656K ﹤0.01% 2507
2023
Q1 		$1.02M Sell
11,225
-1,706
-13% -$232K ﹤0.01% 2722
2022
Q4 		$1.77M Buy
12,931
+603
+5% +$204K ﹤0.01% 2605
2022
Q3 		$10.7M Sell
12,328
-616
-5% -$386K ﹤0.01% 1793
2022
Q2 		$5.67M Buy
12,944
+3,841
+42% +$2M ﹤0.01% 2133
2022
Q1 		$5.78M Buy
9,103
+226
+3% +$142K ﹤0.01% 2211
2021
Q4 		$7.91M Buy
8,877
+855
+11% +$898K ﹤0.01% 2125
2021
Q3 		$10.2M Buy
+8,022
New +$9.72M ﹤0.01% 2000

Other funds holding CANO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Charles Schwab's CANO Position: Q4 2023 in Review

Charles Schwab sold out of Cano Health, Inc. (CANO) in Q4 2023, closing a stake of 7,161 shares — an estimated $182K sold.

Charles Schwab first reported a position in CANO in Q3 2021 and held it in 9 quarters. The position peaked at $10.7M in Q3 2022. 50 funds tracked by Wall St. Rank hold CANO as of Q4 2023.

  • Charles Schwab reported no remaining Cano Health, Inc. position as of Q4 2023 after selling out during the quarter.
  • Charles Schwab sold 7,161 Cano Health, Inc. shares in Q4 2023, an estimated $182K.
  • Charles Schwab first reported a position in Cano Health, Inc. in Q3 2021 and held it in 9 quarters.
  • Charles Schwab's Cano Health, Inc. position peaked at $10.7M in Q3 2022.
  • 50 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q4 2023.

Based on Charles Schwab's 13F filing for Q4 2023, filed 6 Feb 2024.